RAPT Therapeutics, Inc.RAPTNASDAQ
Loading
Free Cash Flow Growth AcceleratingAccelerating
Percentile Rank100
5Y CAGR+126.9%
Studio
Year-over-Year Change

Year-over-year free cash flow growth rate

5Y CAGR
+126.9%/yr
Long-term compound
Percentile
P100
Near historical high
vs 5Y Ago
60.2x
Strong expansion
Streak
1 yr
Consecutive growthAccelerating
PeriodValue
202415.03%
2023-37.08%
2022-15.92%
2021-51.09%
2020-12.45%
20190.25%
2018-29.05%
20170.00%